Crizotinib


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D001145 Arrhythmias, Cardiac PMID:23707608
MESH:D002289 Carcinoma, Non-Small-Cell Lung PMID:20979473
MESH:D003248 Constipation PMID:22954507
MESH:D003967 Diarrhea PMID:21757253; PMID:22954507; PMID:23686600
MESH:D004244 Dizziness PMID:21345110
MESH:D004487 Edema PMID:22954507
MESH:D005767 Gastrointestinal Diseases PMID:20979469; PMID:23020724
MESH:D006331 Heart Diseases PMID:23707608
MESH:D007006 Hypogonadism PMID:22488744; PMID:23686600
MESH:D008231 Lymphopenia PMID:22954507
MESH:D009325 Nausea PMID:21757253; PMID:21823889; PMID:22954507; PMID:23686600
MESH:D009503 Neutropenia PMID:22954507
MESH:D011014 Pneumonia PMID:23686600
MESH:D014786 Vision Disorders PMID:21345110; PMID:21757253; PMID:21823889; PMID:22954507; PMID:23020724; PMID:23686600
MESH:D014839 Vomiting PMID:21823889; PMID:22954507; PMID:23686600
MESH:D017674 Hypophosphatemia PMID:22954507
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:23686600; PMID:31639374

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.